Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Astragalus root extract is a botanical product derived from the roots of *Astragalus membranaceus* or *Astragalus mongholicus*, plants central to Traditional Chinese Medicine (TCM). The extract contains a complex mixture of bioactive compounds, including polysaccharides (astragalans), triterpene saponins (astragalosides I–VIII), and flavonoids (formononetin, calycosin). It is primarily investigated for its immunomodulatory, anti-inflammatory, and antioxidant properties. In clinical research, such as the study conducted by the First Affiliated Hospital of Zhejiang University, it is evaluated for its potential to modulate drug transporters like P-glycoprotein (P-gp), which could lead to significant herb-drug interactions when co-administered with P-gp substrates like fexofenadine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on astragalus root extract.